| Date Filed | Type | Description |
| 08/21/2023 |
4
| Warren Eric (Chief Commercial Officer) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Sold 243 shares
@ $1.414, valued at
$343.6 |
|
| 08/18/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/18/2023 |
4
| Warren Eric (Chief Commercial Officer) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Sold 219 shares
@ $1.624, valued at
$355.7 |
|
| 05/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2023 |
144/A
| Form 144/A - Report of proposed sale of securities: [Amend] |
| 04/19/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/20/2023 |
4
| Warren Eric (Chief Commercial Officer) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Sold 526 shares
@ $1.7823, valued at
$937.5 |
|
| 03/15/2023 |
4
| Warren Eric (Chief Commercial Officer) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Granted 22,300 shares
@ $0
Granted 94,500 options to buy
@ $4.02, valued at
$379.9k
|
|
| 03/08/2023 |
4
| Warren Eric (Chief Commercial Officer) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Sold 5,090 shares
@ $5.055, valued at
$25.7k
|
|
| 10/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/20/2022 |
4
| Warren Eric (Chief Commercial Officer) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Sold 255 shares
@ $6.921, valued at
$1.8k
|
|
| 08/31/2022 |
4
| Warren Eric (Chief Commercial Officer) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Bought 1,000 shares
@ $7.46, valued at
$7.5k
|
|
| 08/18/2022 |
4
| Warren Eric (Chief Commercial Officer) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Sold 199 shares
@ $6.815, valued at
$1.4k
|
|
| 07/20/2022 |
4
| Warren Eric (Chief Commercial Officer) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Sold 431 shares
@ $6.582, valued at
$2.8k
|
|
| 06/21/2022 |
4
| Warren Eric (Chief Commercial Officer) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Sold 256 shares
@ $4.9, valued at
$1.3k
|
|
| 06/09/2022 |
4
| Warren Eric (Chief Commercial Officer) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Granted 52,000 options to buy
@ $6.2, valued at
$322.4k
|
|
| 05/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/09/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |